Additional Advances in Melanoma Research and Clinical Trials With Michael A. Davies, MD, PhD

Claim your CME and NCPD here: https://bit.ly/4iJnCEq Watch Module 1: https://www.youtube.com/watch?v=GxpkIupgTgY&feature=youtu.be Watch Module 2: https://www.youtube.com/watch?v=jnwCEDsViwE&feature=youtu.be View and download the slide deck here: https://www.slideshare.net/slideshow/melanoma-in-minutes-evidence-driven-care-for-improved-patient-outcomes-module-1/283120169 The treatment landscape for melanoma continues to evolve at a rapid pace, with new clinical trial data and therapeutic modalities refining how clinicians approach both early-stage and advanced disease. Michael A. Davies, MD, PhD, Professor and Chairman of the Department of Melanoma Medical Oncology at the University of Texas MD Anderson Cancer Center, recently chaired i3 Health’s CME/NCPD/AAPA activity, "Melanoma in Minutes: Evidence-Driven Care for Improved Patient Outcomes." With numerous new developments in melanoma treatment over recent months, Dr. Davies sat down again to share these critical updates that are impacting practice. Follow us here: Facebook https://www.facebook.com/i3Health Instagram https://www.instagram.com/i3health Linkedin https://www.linkedin.com/company/i3health Soundcloud https://soundcloud.com/i3-health X https://twitter.com/i3health